19641-0 |
Oxazepam cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Oxazepam cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19641-0 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Oxazepam CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Alepam; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Temazepam metabolite; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19642-8 |
oxyCODONE |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
oxyCODONE [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19642-8 |
|
Screen |
|
|
Both |
|
|
|
0 |
oxyCODONE Ur Ql Scn |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Lortab; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn; Vicodin |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19643-6 |
oxyCODONE |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
oxyCODONE [Presence] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19643-6 |
|
Confirm |
|
|
Both |
|
|
|
0 |
oxyCODONE Ur Ql Cfm |
|
|
|
|
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Lortab; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn; Vicodin |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19644-4 |
oxyCODONE cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
oxyCODONE cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19644-4 |
|
Screen |
|
|
Observation |
|
|
|
0 |
oxyCODONE CtO Ur Scn-mCnc |
|
|
|
Y |
|
CtO; DRUG/TOXICOLOGY; Drugs; Level; Lortab; Mass concentration; OxyContin; Percocet; Percodan; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn; Vicodin |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19645-1 |
oxyCODONE cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
oxyCODONE cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19645-1 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
oxyCODONE CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Lortab; Mass concentration; OxyContin; Percocet; Percodan; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Vicodin |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19646-9 |
oxyMORphone |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
oxyMORphone [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19646-9 |
|
Screen |
|
|
Both |
|
|
|
0 |
oxyMORphone Ur Ql Scn |
|
|
|
|
|
14-Hydroxydihydromorphinone; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Numorphan; Numorphone; Opana; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19648-5 |
oxyMORphone |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
oxyMORphone [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19648-5 |
|
|
|
|
Both |
|
|
|
0 |
oxyMORphone Ur-mCnc |
|
|
|
Y |
|
14-Hydroxydihydromorphinone; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Numorphan; Numorphone; Opana; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19649-3 |
oxyMORphone cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
oxyMORphone cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19649-3 |
|
Screen |
|
|
Observation |
|
|
|
0 |
oxyMORphone CtO Ur Scn-mCnc |
|
|
|
Y |
|
14-Hydroxydihydromorphinone; CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Numorphan; Numorphone; Opana; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
1965-3 |
Bile |
PrThr |
Stool |
Pt |
Ord |
|
|
ACTIVE |
Bile [Presence] in Stool |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
1965-3 |
|
|
|
|
Both |
|
|
|
0 |
Bile Stl Ql |
|
|
|
|
|
Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19650-1 |
oxyMORphone cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
oxyMORphone cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19650-1 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
oxyMORphone CtO Ur Cfm-mCnc |
|
|
|
Y |
|
14-Hydroxydihydromorphinone; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Numorphan; Numorphone; Opana; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19651-9 |
Para hydroxyamphetamine |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Para hydroxyamphetamine [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19651-9 |
|
Screen |
|
|
Both |
|
|
|
0 |
P-OH-Amphet Ur Ql Scn |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Methylthyramine; Ordinal; Para hydroxy amphetamine; P-OH-Amphet; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19652-7 |
Para hydroxyamphetamine |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
Para hydroxyamphetamine [Presence] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19652-7 |
|
Confirm |
|
|
Both |
|
|
|
0 |
P-OH-Amphet Ur Ql Cfm |
|
|
|
|
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Methylthyramine; Ordinal; Para hydroxy amphetamine; P-OH-Amphet; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19653-5 |
Para hydroxyamphetamine cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19653-5 |
|
Screen |
|
|
Observation |
|
|
|
0 |
P-OH-Amphet CtO Ur Scn-mCnc |
|
|
|
Y |
|
CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Methylthyramine; Para hydroxy amphetamine; P-OH-Amphet; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19654-3 |
Para hydroxyamphetamine cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19654-3 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
P-OH-Amphet CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Methylthyramine; Para hydroxy amphetamine; P-OH-Amphet; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19655-0 |
PENTobarbital |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
PENTobarbital [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19655-0 |
|
Screen |
|
|
Both |
|
|
|
0 |
Pentobarb Ur Ql Scn |
|
|
|
|
|
Addiction; Barbiturate; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Nembutal; Ordinal; Pentobarb; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19657-6 |
PENTobarbital cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
PENTobarbital cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19657-6 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Pentobarb CtO Ur Scn-mCnc |
|
|
|
Y |
|
Barbiturate; CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Nembutal; Pentobarb; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19658-4 |
PENTobarbital cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
PENTobarbital cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19658-4 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Pentobarb CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Barbiturate; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Nembutal; Pentobarb; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19659-2 |
Phencyclidine |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Phencyclidine [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19659-2 |
|
Screen |
|
|
Both |
|
|
|
0 |
PCP Ur Ql Scn |
|
|
|
|
|
Addiction; Angel dust; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; PCP; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sernylan; UA; UniversalLabOrders; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
Property changed from ACnc to reflect the fact that interpretation is based on a cut-off value (threshold); The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
1966-1 |
Bile acid |
MCnc |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Bile acid [Mass/volume] in Exhaled gas |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
1966-1 |
|
|
|
|
Both |
|
|
|
0 |
Bile Ac ExG-mCnc |
|
|
|
Y |
|
Acd; Acids; Bile acid.total; Bile salt; Breath; Chemistry; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.34 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
19660-0 |
Phencyclidine cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Phencyclidine cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19660-0 |
|
Screen |
|
|
Observation |
|
|
|
0 |
PCP CtO Ur Scn-mCnc |
|
|
|
Y |
|
Angel dust; CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; PCP; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; Sernylan; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19661-8 |
Phencyclidine cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Phencyclidine cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19661-8 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
PCP CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Angel dust; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; PCP; Point in time; QNT; Quan; Quant; Quantitative; Random; Sernylan; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19662-6 |
Phenmetrazine |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Phenmetrazine [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19662-6 |
|
Screen |
|
|
Both |
|
|
|
0 |
Phenmetrazine Ur Ql Scn |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Oxazimedrine; Point in time; PotentialForAbuse; PR; Preludin endurets; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19664-2 |
Phenmetrazine cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Phenmetrazine cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19664-2 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Phenmetrazine CtO Ur Scn-mCnc |
|
|
|
Y |
|
CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Oxazimedrine; Point in time; Preludin endurets; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19665-9 |
Phenmetrazine cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Phenmetrazine cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19665-9 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Phenmetrazine CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Oxazimedrine; Point in time; Preludin endurets; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19666-7 |
PHENobarbital |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
PHENobarbital [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19666-7 |
|
Screen |
|
|
Both |
|
|
|
0 |
Phenobarb Ur Ql Scn |
|
|
|
|
|
Barbiturate; c417; DRUG/TOXICOLOGY; Drugs; Luminal; Nirvonal; Ordinal; PHBR; Phenobarb; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |